Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients.
Clinical trial NCT06731738 · COMPLETED
Trial details
- NCT number
- NCT06731738
- Sponsor
- IC TARGETS AS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-22
- Primary completion
- 2025-11-29
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.